Amy Lum
Room 3-218, 675 West 10th Ave
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas.
Journal: Neoplasia (New York, N.Y.)
Published: May 15, 2025
Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 06, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression.
Journal: The Journal of pathology
Published: January 26, 2025
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 26, 2024
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.
Journal: Gynecologic oncology
Published: September 23, 2024
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas.
Journal: Histopathology
Published: August 09, 2024
Prognostic Significance of Disseminated Tumor Cells in Bone Marrow for Endometrial Carcinoma Patients.
Journal: Journal of clinical medicine
Published: July 01, 2024
The unique metabolome of clear cell ovarian carcinoma.
Journal: The Journal of pathology
Published: February 25, 2024
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 22, 2024
Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas.
Journal: Journal of gynecologic oncology
Published: February 08, 2024
Rapid brain tumor classification from sparse epigenomic data.
Journal: Nature medicine
Published: February 07, 2024
Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting CDKN2A/B status.
Journal: Neuro-oncology advances
Published: January 30, 2024
Last Updated: 09/26/2026